“Bempedoic Acid: A Promising Alternative to Statins for Lowering Cardiovascular Risk in Statin-Intolerant Patients – Study Finds”

2023-05-18 06:00:00

In patients who cannot tolerate statins due to side effects, bempedoic acid leads to a lower risk of major cardiovascular events. That is the conclusion of a large international trial that was recently published in The New England Journal of Medicine (2023; online 13 april).

For both primary and secondary prevention…

The entire content of this article is only accessible to subscribers.

Read 3 articles FREE

Make an account. Free and without obligation.

I want 3x free

Always access to all NTvG publications?

Subscribe today!

Take the introductory subscription

€ 32.95 for 12 weeks!

I want to meet

Do you already have a subscription? login